AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Nirglic-M 30 SR Tablet

Prescription Icon
Prescription Required

Marketer

Nirosha Lifesciences

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Nirglic-M 30 SR Tablet

Glucotwin SR 30 tablets are classified as antidiabetic medications, combining two active ingredients for managing type 2 diabetes in adults. This medication helps regulate blood glucose levels. Glucotwin SR 30 should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as advised by your doctor. Lifestyle significantly impacts diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a rapid-acting glucose source (e.g., sugary snacks, juice) to counteract hypoglycemia. Alcohol consumption should be limited due to increased hypoglycemia risk. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Nirglic-M 30 SR Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Nirglic-M 30 SR Tablet

Adult-onset diabetes

Major Benefits of Nirglic-M 30 SR Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Nirglic-M 30 SR Tablet whole; do not crush, chew, or break it. Administer this medication with food.

Common Side effects of Nirglic-M 30 SR Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Nirglic-M 30 SR Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Nirglic-M 30 SR Tablet with a meal.

How Nirglic-M 30 SR Tablet works:

Gliclazide and metformin are combined in the extended-release Nirglic-M 30 SR Tablet to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking Nirglic-M 30 SR Tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Nirglic-M 30 SR Tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Nirglic-M 30 SR Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Nirglic-M 30 SR Tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before use. Nirglic-M 30 SR Tablets are contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Nirglic-M 30 SR Tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Nirglic-M 30 SR Tablet :

Should you forget to take a Nirglic-M 30 SR Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Nirglic-M 30 SR Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Nirglic-M 30 SR Tablet

Nirglic-M 30 SR Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's unsuitable for treating type 1 diabetes.
Nirglic-M 30 SR Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Nirglic-M 30 SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nirglic-M 30 SR Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is less likely to occur if you avoid using this medication with kidney disease, advanced age, or excessive alcohol consumption. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue use and seek immediate medical attention.
Prolonged Nirglic-M 30 SR Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Nirglic-M 30 SR Tablets are contraindicated in patients allergic to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol and Nirglic-M 30 SR Tablets is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Nirglic-M 30 SR Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Nirglic-M 30 SR Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Nirglic-M 30 SR Tablets can cause low blood sugar (hypoglycemia), leading to symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are taken concurrently. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Nirglic-M 30 SR Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Nirglic-M 30 SR Tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Nirglic-M 30 SR Tablets are contraindicated in patients allergic to any component or excipient, and in those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Nirglic-M 30 SR Tablet and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Nirglic-M 30 SR Tablet
68
MRP 79
13% off